Ligand binding triggers IGF-1R signaling via the PI3K/Akt and MEK/ERK pathways, as well as nuclear IGF-1R transport to activate gene transcription, thereby regulating resistance to apoptosis, cell proliferation, and cell cycle progression, as well as promoting tumor progression [6,9,10]. This evidence concerns the gene IGF1R and neoplasm.